ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer and BioNTech’s Covid-19 vaccine shows 100% efficacy in adolescents
April 02, 2021Pfizer and BioNTech have reported that a Phase III trial of their Covid-19 vaccine, BNT162b2, showed 100% efficacy and strong antibody responses in adolescents aged 12 to 15 years with or without prior evidence of SARS-CoV-2 infection. -
Pfizer COVID-19 vaccine safe, efficacious for adolescents
April 02, 2021Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer. -
80 adolescents a day will still die of AIDS by 2030, despite slowdown in epidemic: UN
December 03, 2018Currently, 3 million persons 19 years and younger, are infected with HIV worldwide -
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
The sBLA is supported by data from a pivotal Phase 3 trial evaluating the efficacy and safety of Dupixent monotherapy in adolescent patients with moderate-to-severe atopic dermatitis, which were presented at the European Academy of Dermatology and Venereo
Pharma Sources Insight January 2025
